Thermo Fisher Scientific (NYSE:TMO) confirms that its sweetened €43.00 per share in cash bid for diagnostic test maker Qiagen (NYSE:QGEN) will expire at 6:00 pm ET on Monday, August 10.
The company says its offer, revised upward from €39 after institutional stockholders rebelled, is its best and final and will automatically terminate if less than 66.67% of QGEN shares are tendered.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.